The company said the new program enables employers in the communities it serves to act on helping manage diabetes, something the employers have noted as one of their top two concerns.
Actelion will spin off its drug discovery operations and early-stage clinical development assets into a newly created company to its shareholders in the form of a dividend immediately prior to the deal closing.
FDA determines Dalfampridine Extended-Release tablets, 10 mg is bioequivalent to Amprya.
McKesson reported revenues of $50.1 billion, up 5%, for the third quarter ended Dec. 31.
Captain Mark Kelly will discuss how to better manage teams, deal with changing circumstances and use detailed plans to accomplish remarkable things in the face of seemingly insurmountable obstacles.
The bill reached impressive levels of bipartisan support in the prior Congress, with half of the Senate and two-thirds of the U.S. House of Representatives co-sponsoring the measure.
The news was announced in conjunction with the company's fourth quarter earnings call, and is part of the company's ongoing portfolio management.